Key facts
- It has raised $14.3M; the latest was Grant ($2.8M) in Jun 2025.
- Notable investors include Plug and Play Tech Center, MassChallenge, European Innovation Council, EIT Food, Big Idea Ventures — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for PFx Biotech
- ·The full record, as it builds
Funding rounds
No funding rounds for PFx Biotech are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PFx Biotech
Developer of a next-generation fermentation platform intended to produce high-value bioactive proteins and functional protein-based ingredients. The company's technology leverages precision fermentation to sustainably produce human-identical milk proteins with clinically relevant bioactivities, including immune system support, antimicrobial and antiviral properties, and stress modulation, enabling enhancement in human health and nutrition while significantly reducing environmental impact by lowering water consumption, greenhouse gas emissions, and land use compared to conventional dairy.
- Sector
- Healthcare
- HQ
- Porto, Portugal
- Founded
- 2022
- Employees
- 5
- Website
- pfxbiotech.com/
- Ownership
- Privately Held (backing)
PFx Biotech doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PFx Biotech shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PFx Biotech in its N-PORT filings yet. We sweep new filings monthly.